Can You Take Quetiapine with Diazepam?
A plain-English look at the major interaction between Quetiapine (Seroquel XR) and Diazepam (Diazepam Elixir) — what it means, why it happens, and what to talk to your doctor or pharmacist about.
Taking Quetiapine (Seroquel XR) with Diazepam (Diazepam Elixir) is a major drug interaction that should be avoided. Life-threatening respiratory depression, overdose, coma, and death. Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
Not sure about your specific combination? Check it in the Drug Interaction Checker →
Key Takeaways
- Interaction severity: Major
- Risk: Life-threatening respiratory depression, overdose, coma, and death.
- Mechanism: Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
- Quetiapine: S4 in Australia, moderate risk
- Diazepam: S4 in Australia, moderate risk
- Claims action: Flag for immediate prescriber review. Document intervention in claim file.
Quetiapine vs Diazepam at a Glance
| Property | Quetiapine | Diazepam |
|---|---|---|
| Brand names | Seroquel XR, Tevatiapine XR, Quetia XR | Diazepam Elixir, APX-Diazepam, DIAZEPAM-WGR |
| Drug class | opioid | benzo |
| Risk level | moderate | moderate |
| TGA Schedule (AU) | S4 | S4 |
Why Is This Combination Dangerous?
Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.
All Australian state workers compensation schemes (SIRA NSW, WorkSafe VIC, WorkCover QLD) flag concurrent opioid and benzodiazepine prescribing as high-risk. SIRA best practice guidelines explicitly recommend avoiding this combination except in exceptional circumstances with specialist oversight.
United Kingdom NICE / MHRA / FPM
NICE NG193 (Chronic Pain) recommends against initiating opioids for chronic primary pain. The Faculty of Pain Medicine (FPM) Opioids Aware guidelines strongly advise against concurrent opioid and benzodiazepine prescribing. For personal injury claims in the UK, this combination should be flagged for specialist review. Costs for medication review may be recoverable as a disbursement.
United States FDA / CDC / State WC
The FDA requires a Boxed Warning on all opioid and benzodiazepine products about the risks of concurrent use. The CDC Clinical Practice Guideline (2022) recommends clinicians avoid prescribing opioids and benzodiazepines concurrently whenever possible. Most state workers compensation drug formularies flag or restrict this combination.
What Claims Professionals Should Do
- Flag immediately as a high-risk prescribing pattern in the claim file
- Request urgent prescriber review with documented clinical justification for the combination
- Consider an independent medical examination if the prescriber cannot provide adequate justification
- Assess work capacity impact as the combination significantly increases sedation and impairment risk
- Document all interventions for audit trail and compliance purposes
- Check Reasonable and Necessary status for both medications against the compensable injury
Clinical reference
A clinical summary of Quetiapine and Diazepam drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.
Severity assessment
Major. Concomitant use of diazepam and quetiapine can lead to profound central nervous system (CNS) depression, increasing the risk of severe sedation, respiratory depression, and potentially fatal oversedation [1, 2, 3].
Mechanism (plain English)
Both diazepam and quetiapine act on the brain to slow down its activity. Diazepam, a benzodiazepine, enhances the effect of a natural calming chemical in the brain called gamma-aminobutyric acid (GABA), leading to sedative, anxiety-reducing, and muscle-relaxing effects [4]. Quetiapine, an antipsychotic, also has sedative properties due to its effects on various brain receptors, including histamine and adrenergic receptors [5]. When taken together, their individual sedative effects add up, leading to a much stronger overall slowing of brain activity. This additive effect is primarily pharmacodynamic, meaning the drugs affect the body in similar ways, rather than one drug changing how the body processes the other [6].
Evidence level
Regulator-flagged. The interaction is highlighted in the British National Formulary (BNF) and implied by general warnings in regulatory product information regarding concomitant use of CNS depressants [1, 4, 5].
Top regulator advisories (cite verbatim or close paraphrase)
- TGA (Australia): No pair-specific public advisory found. Applicable product information for diazepam (Valium) warns against the simultaneous ingestion of alcohol and other CNS-depressant drugs [7]. Product information for quetiapine (Seroquel XR) lists somnolence and dizziness as common adverse reactions [8].
- MHRA / NICE (UK): The British National Formulary (BNF) states that both quetiapine and diazepam have effects on the CNS and can cause sedation, which might affect the ability to perform skilled tasks [1].
- FDA / CDC (US): The FDA label for diazepam (Valium) warns that concomitant use of benzodiazepines and other CNS depressants may result in profound sedation, respiratory depression, coma, and death [4]. The FDA label for quetiapine (Seroquel) lists somnolence and dizziness as common adverse reactions and notes that in vitro, quetiapine did not affect the binding of diazepam to human serum albumin, and vice versa, indicating no significant pharmacokinetic interaction at this level [5, 6].
- EMA (Europe): No specific pair-specific advisory found, but general warnings regarding CNS depressants would apply.
Clinical risk factors that elevate the danger
Clinical risk factors that elevate the danger include advanced age, pre-existing respiratory conditions (e.g., COPD, sleep apnea), hepatic impairment, renal impairment, concomitant use of other CNS depressants (e.g., alcohol, opioids, other sedatives), and higher doses of either medication [4, 5]. Patients who are new to either medication or have a history of substance abuse may also be at increased risk.
What a patient should be told
- Risk of severe drowsiness: Combining diazepam and quetiapine can make you very sleepy, dizzy, and confused, which can be dangerous, especially when driving or operating machinery.
- Do not stop suddenly: Never stop taking either medication suddenly without talking to your doctor or pharmacist, as this can lead to serious withdrawal symptoms.
- Watch for warning signs: Be aware of signs of excessive sedation, such as extreme drowsiness, difficulty waking up, slow or shallow breathing, or unresponsiveness. If these occur, seek immediate medical attention.
- Discuss alternatives: Talk to your doctor or pharmacist about all medications you are taking, including over-the-counter drugs and supplements, to ensure this combination is safe for you. They may consider safer alternatives or adjust your doses.
- Urgent care triggers: If you experience severe difficulty breathing, extreme confusion, or lose consciousness, call emergency services immediately.
Top 3 sources (with full citation)
- Diazepam | Interactions - BNF - NICE. National Institute for Health and Care Excellence (NICE). https://bnf.nice.org.uk/interactions/diazepam/. Accessed June 1, 2026.
- Diazepam + Quetiapine: Can You Take Them Together? Drugs.com. https://www.drugs.com/drug-interactions/diazepam-with-quetiapine-862-0-1979-0.html. Accessed June 1, 2026.
- Risks of Combining Quetiapine with Diazepam. DrOracle.ai. https://www.droracle.ai/articles/305224/what-are-the-risks-of-combining-quetiapine-atypical-antipsychotic. Accessed June 1, 2026.
Notes for the reviewing pharmacist
The primary concern with this interaction is additive CNS depression, leading to profound sedation and respiratory compromise. While pharmacokinetic interactions at the protein binding level have been ruled out [6], the pharmacodynamic synergy is significant. Close monitoring for signs of oversedation is crucial, especially in vulnerable populations such as the elderly or those with respiratory comorbidities. Patient education should emphasize the risks of impaired psychomotor function and the importance of avoiding other CNS depressants, including alcohol. Consider dose adjustments or alternative therapies if the combination is deemed unavoidable.
Source metadata JSON
Sources used in this brief (7)
- https://bnf.nice.org.uk/interactions/diazepam/
- https://www.drugs.com/drug-interactions/diazepam-with-quetiapine-862-0-1979-0.html
- https://www.droracle.ai/articles/305224/what-are-the-risks-of-combining-quetiapine-atypical-antipsychotic
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013263s094lbl.pdf
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020639s074lbl.pdf
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf
- https://www.tga.gov.au/resources/artg/48566
Check this medication against your full medication list
Check all interactions for Quetiapine and Diazepam across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.